Utah Medical Products EBITDA Margin 2012-2025 | UTMD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Utah Medical Products (UTMD) over the last 10 years. The current EBITDA margin for Utah Medical Products as of September 30, 2025 is .
| Utah Medical Products EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $0.04B | $0.02B | 38.46% |
| 2025-06-30 | $0.04B | $0.02B | 41.03% |
| 2025-03-31 | $0.04B | $0.02B | 41.03% |
| 2024-12-31 | $0.04B | $0.02B | 42.50% |
| 2024-09-30 | $0.04B | $0.02B | 41.86% |
| 2024-06-30 | $0.05B | $0.02B | 43.48% |
| 2024-03-31 | $0.05B | $0.02B | 44.90% |
| 2023-12-31 | $0.05B | $0.02B | 45.10% |
| 2023-09-30 | $0.05B | $0.03B | 47.17% |
| 2023-06-30 | $0.05B | $0.03B | 49.06% |
| 2023-03-31 | $0.05B | $0.03B | 50.94% |
| 2022-12-31 | $0.05B | $0.03B | 51.92% |
| 2022-09-30 | $0.05B | $0.03B | 52.94% |
| 2022-06-30 | $0.05B | $0.03B | 52.94% |
| 2022-03-31 | $0.05B | $0.03B | 52.94% |
| 2021-12-31 | $0.05B | $0.03B | 54.00% |
| 2021-09-30 | $0.05B | $0.03B | 53.06% |
| 2021-06-30 | $0.05B | $0.02B | 52.17% |
| 2021-03-31 | $0.04B | $0.02B | 50.00% |
| 2020-12-31 | $0.04B | $0.02B | 50.00% |
| 2020-09-30 | $0.04B | $0.02B | 50.00% |
| 2020-06-30 | $0.04B | $0.02B | 50.00% |
| 2020-03-31 | $0.05B | $0.02B | 51.06% |
| 2019-12-31 | $0.05B | $0.02B | 51.06% |
| 2019-09-30 | $0.05B | $0.02B | 51.11% |
| 2019-06-30 | $0.04B | $0.02B | 51.16% |
| 2019-03-31 | $0.04B | $0.02B | 52.38% |
| 2018-12-31 | $0.04B | $0.02B | 52.38% |
| 2018-09-30 | $0.04B | $0.02B | 52.38% |
| 2018-06-30 | $0.04B | $0.02B | 52.38% |
| 2018-03-31 | $0.04B | $0.02B | 52.38% |
| 2017-12-31 | $0.04B | $0.02B | 51.22% |
| 2017-09-30 | $0.04B | $0.02B | 50.00% |
| 2017-06-30 | $0.04B | $0.02B | 50.00% |
| 2017-03-31 | $0.04B | $0.02B | 48.72% |
| 2016-12-31 | $0.04B | $0.02B | 48.72% |
| 2016-09-30 | $0.04B | $0.02B | 50.00% |
| 2016-06-30 | $0.04B | $0.02B | 50.00% |
| 2016-03-31 | $0.04B | $0.02B | 50.00% |
| 2015-12-31 | $0.04B | $0.02B | 50.00% |
| 2015-09-30 | $0.04B | $0.02B | 50.00% |
| 2015-06-30 | $0.04B | $0.02B | 48.78% |
| 2015-03-31 | $0.04B | $0.02B | 48.78% |
| 2014-12-31 | $0.04B | $0.02B | 48.78% |
| 2014-09-30 | $0.04B | $0.02B | 46.34% |
| 2014-06-30 | $0.04B | $0.02B | 45.00% |
| 2014-03-31 | $0.04B | $0.02B | 45.00% |
| 2013-12-31 | $0.04B | $0.02B | 45.00% |
| 2013-09-30 | $0.04B | $0.02B | 45.00% |
| 2013-06-30 | $0.04B | $0.02B | 47.50% |
| 2013-03-31 | $0.04B | $0.02B | 45.00% |
| 2012-12-31 | $0.04B | $0.02B | 43.90% |
| 2012-09-30 | $0.04B | $0.02B | 43.90% |
| 2012-06-30 | $0.04B | $0.02B | 40.48% |
| 2012-03-31 | $0.04B | $0.02B | 40.48% |
| 2011-12-31 | $0.04B | $0.01B | 36.84% |
| 2011-09-30 | $0.03B | $0.01B | 35.29% |
| 2011-06-30 | $0.03B | $0.01B | 34.48% |
| 2011-03-31 | $0.03B | $0.01B | 32.00% |
| 2010-12-31 | $0.02B | $0.01B | 33.33% |
| 2010-09-30 | $0.02B | $0.01B | 37.50% |
| 2010-06-30 | $0.03B | $0.01B | 40.00% |
| 2010-03-31 | $0.03B | $0.01B | 40.00% |
| 2009-12-31 | $0.03B | $0.01B | 44.00% |
| 2009-09-30 | $0.03B | $0.01B | 38.46% |
| 2009-06-30 | $0.03B | $0.01B | 38.46% |
| 2009-03-31 | $0.03B | $0.01B | 40.74% |
| 2008-12-31 | $0.03B | $0.01B | 39.29% |
| 2008-09-30 | $0.03B | $0.01B | 42.86% |
| 2008-06-30 | $0.03B | $0.01B | 42.86% |
| 2008-03-31 | $0.03B | $0.01B | 42.86% |
| 2007-12-31 | $0.03B | $0.01B | 42.86% |
| 2007-09-30 | $0.03B | $0.01B | 42.86% |
| 2007-06-30 | $0.03B | $0.01B | 42.86% |
| 2007-03-31 | $0.03B | $0.01B | 42.86% |
| 2006-12-31 | $0.03B | $0.01B | 42.86% |
| 2006-09-30 | $0.03B | $0.01B | 39.29% |
| 2006-06-30 | $0.03B | $0.01B | 35.71% |
| 2006-03-31 | $0.03B | $0.01B | 35.71% |
| 2005-12-31 | $0.03B | $0.01B | 35.71% |
| 2005-09-30 | $0.03B | $0.02B | 59.26% |
| 2005-06-30 | $0.03B | $0.02B | 62.96% |
| 2005-03-31 | $0.03B | $0.02B | 62.96% |
| 2004-12-31 | $0.03B | $0.02B | 62.96% |
| 2004-09-30 | $0.03B | $0.04B | 125.00% |
| 2004-06-30 | $0.03B | $0.04B | 125.00% |
| 2004-03-31 | $0.03B | $0.04B | 125.00% |
| 2003-12-31 | $0.03B | $0.04B | 125.00% |
| 2003-09-30 | $0.03B | $0.01B | 42.86% |
| 2003-06-30 | $0.03B | $0.01B | 42.86% |
| 2003-03-31 | $0.03B | $0.01B | 42.86% |
| 2002-12-31 | $0.03B | $0.01B | 42.86% |
| 2002-09-30 | $0.03B | $0.01B | 42.86% |
| 2002-06-30 | $0.03B | $0.01B | 42.86% |
| 2002-03-31 | $0.03B | $0.01B | 42.86% |
| 2001-12-31 | $0.03B | $0.01B | 42.86% |
| 2001-09-30 | $0.03B | $0.01B | 42.86% |
| 2001-06-30 | $0.03B | $0.01B | 42.86% |
| 2001-03-31 | $0.03B | $0.01B | 42.86% |
| 2000-12-31 | $0.03B | $0.01B | 39.29% |
| 2000-09-30 | $0.03B | $0.01B | 37.93% |
| 2000-06-30 | $0.03B | $0.01B | 36.67% |
| 2000-03-31 | $0.03B | $0.01B | 36.67% |
| 1999-12-31 | $0.03B | $0.01B | 36.67% |
| 1999-09-30 | $0.03B | $0.01B | 34.48% |
| 1999-06-30 | $0.03B | $0.01B | 32.14% |
| 1999-03-31 | $0.03B | $0.01B | 28.57% |
| 1998-12-31 | $0.03B | $0.01B | 29.63% |
| 1998-09-30 | $0.03B | $0.01B | 48.15% |
| 1998-06-30 | $0.03B | $0.02B | 55.56% |
| 1998-03-31 | $0.03B | $0.02B | 72.00% |
| 1997-12-31 | $0.02B | $0.02B | 87.50% |
| 1997-09-30 | $0.03B | $0.02B | 73.08% |
| 1997-06-30 | $0.03B | $0.02B | 62.07% |
| 1997-03-31 | $0.03B | $0.02B | 67.65% |
| 1996-12-31 | $0.04B | $0.02B | 53.85% |
| 1996-09-30 | $0.04B | $0.02B | 46.34% |
| 1996-06-30 | $0.04B | $0.02B | 45.24% |
| 1996-03-31 | $0.04B | $0.01B | 27.91% |
| 1995-12-31 | $0.04B | $0.01B | 27.91% |
| 1995-09-30 | $0.04B | $0.01B | 26.19% |
| 1995-06-30 | $0.04B | $0.01B | 26.83% |
| 1995-03-31 | $0.04B | $0.01B | 27.50% |
| 1994-12-31 | $0.04B | $0.01B | 25.64% |
| 1994-09-30 | $0.04B | $0.01B | 26.32% |
| 1994-06-30 | $0.04B | $0.01B | 24.32% |
| 1994-03-31 | $0.04B | $0.01B | 22.22% |
| 1993-12-31 | $0.04B | $0.01B | 22.22% |
| 1993-09-30 | $0.04B | $0.01B | 24.32% |
| 1993-06-30 | $0.04B | $0.01B | 27.03% |
| 1993-03-31 | $0.04B | $0.01B | 27.03% |
| 1992-12-31 | $0.04B | $0.01B | 27.78% |
| 1992-09-30 | $0.03B | $0.01B | 26.47% |
| 1992-06-30 | $0.03B | $0.01B | 24.24% |
| 1992-03-31 | $0.03B | $0.01B | 25.81% |
| 1991-12-31 | $0.03B | $0.01B | 26.67% |
| 1991-09-30 | $0.03B | $0.01B | 27.59% |
| 1991-06-30 | $0.03B | $0.01B | 29.63% |
| 1991-03-31 | $0.03B | $0.01B | 28.00% |
| 1990-12-31 | $0.02B | $0.01B | 26.09% |
| 1990-09-30 | $0.02B | $0.01B | 23.81% |
| 1990-06-30 | $0.02B | $0.00B | 20.00% |
| 1990-03-31 | $0.02B | $0.00B | 21.05% |
| 1989-12-31 | $0.02B | $0.00B | 22.22% |
| 1989-09-30 | $0.02B | $0.00B | 23.53% |
| 1989-06-30 | $0.02B | $0.00B | 20.00% |
| 1989-03-31 | $0.01B | $0.00B | 14.29% |
| 1988-12-31 | $0.01B | $0.00B | 8.33% |
| 1988-09-30 | $0.01B | 0 | 0.00% |
| 1988-06-30 | $0.01B | 0 | 0.00% |
| 1988-03-31 | $0.01B | 0 | 0.00% |
| 1987-12-31 | $0.01B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.198B | $0.039B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $190.250B | 21.25 |
| EssilorLuxottica (ESLOY) | France | $141.053B | 0.00 |
| Stryker (SYK) | United States | $140.785B | 27.01 |
| Boston Scientific (BSX) | United States | $136.192B | 31.14 |
| Medtronic (MDT) | Ireland | $131.676B | 18.24 |
| Medline (MDLN) | United States | $59.144B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.791B | 0.00 |
| Agilent Technologies (A) | United States | $38.383B | 24.26 |
| ResMed (RMD) | United States | $37.110B | 24.78 |
| GE HealthCare Technologies (GEHC) | United States | $36.492B | 17.45 |
| Koninklijke Philips (PHG) | Netherlands | $27.828B | 18.18 |
| Terumo (TRUMY) | Japan | $19.515B | 22.05 |
| Insulet (PODD) | United States | $18.052B | 56.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.087B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.556B | 0.00 |
| Baxter (BAX) | United States | $10.214B | 8.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.023B | 28.85 |
| Demant (WILYY) | Denmark | $7.483B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.410B | 13.43 |
| Envista Holdings (NVST) | United States | $3.825B | 21.94 |
| BillionToOne (BLLN) | United States | $3.824B | 0.00 |
| ICU Medical (ICUI) | United States | $3.739B | 23.74 |
| Prestige Consumer Healthcare (PBH) | United States | $3.147B | 14.35 |
| Haemonetics (HAE) | United States | $3.079B | 13.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.007B | 0.00 |
| Neogen (NEOG) | United States | $2.230B | 48.81 |
| Perrigo (PRGO) | Ireland | $1.971B | 4.94 |
| LeMaitre Vascular (LMAT) | United States | $1.960B | 39.45 |
| QuidelOrtho (QDEL) | United States | $1.878B | 12.07 |
| AtriCure (ATRC) | United States | $1.831B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.699B | 16.97 |
| Curaleaf Holdings (CURLF) | Canada | $1.472B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.459B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.394B | 61.09 |
| AdaptHealth (AHCO) | United States | $1.368B | 19.80 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.159B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.075B | 319.00 |
| Capricor Therapeutics (CAPR) | United States | $1.056B | 0.00 |
| InMode (INMD) | Israel | $1.051B | 11.87 |
| Tilray Brands (TLRY) | Canada | $0.867B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.862B | 0.00 |
| Omeros (OMER) | United States | $0.831B | 0.00 |
| Valneva SE (VALN) | France | $0.788B | 0.00 |
| CeriBell (CBLL) | United States | $0.750B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.594B | 16.09 |
| Brainsway (BWAY) | Israel | $0.455B | 77.50 |
| Verano Holdings (VRNO) | United States | $0.450B | 0.00 |
| Cerus (CERS) | United States | $0.446B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.372B | 0.00 |
| Evolus (EOLS) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.304B | 24.24 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.255B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.228B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.222B | 130.67 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.199B | 0.00 |
| High Tide (HITI) | Canada | $0.198B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.196B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.176B | 1.76 |
| Apyx Medical (APYX) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.77 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.109B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.54 |
| Exagen (XGN) | United States | $0.087B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 23.50 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Nephros (NEPH) | United States | $0.049B | 35.15 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 17.86 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Flora Growth (ZSTK) | United States | $0.008B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |